Godavari Drugs Board Approves MOA Amendment for Nutraceuticals

Godavari Drugs Limited's Board of Directors has approved an amendment to the company's Memorandum of Association (MOA). The key change involves inserting a new main object clause to include the business of nutraceuticals, dietary supplements, natural extracts, food ingredients, and allied products. This expansion aims to allow the company to formally engage in domestic and export marketing, contract manufacturing, and own manufacturing within this growing sector. The amendment is subject to shareholder approval via a Special Resolution at the upcoming 38th Annual General Meeting (AGM) scheduled for September 25, 2026, and subsequent filing with the Ministry of Corporate Affairs. The alteration is additive and does not affect existing business or shareholder rights.